Stocks Finish Mixed Oct 14, 2009
Abbott Laboratories (). Oct-14-9:00 a.m. ET. (BusinessWeek)
Calendar of Major Business Events for Wednesday Oct 13, 2009
Abbott Laboratories releases third-quarter financial results. NEW YORK JPMorgan Chase eleases third-quarter financial results. (ABC News -- Wire)
Business Briefing Oct 12, 2009
-- Third-quarter financial results from Abbott Laboratories and JPMorgan Chase. TH. (San Francisco Chronicle -- Business)
Visa's New Goal Oct 10, 2009
Del Monte's Pre-Earnings Move After hours: Hovnanian Enterprises disappoints; Abbott Laboratories acquires Visiogen. Initial Claims On Deck Movado and Quiksilver to report earnings. (Forbes -- Business)
Depomed Says Shingles Pain Drug Meets Study Goal Oct 6, 2009
That business is being bought by Abbott Laboratories for $7. 6 billion. (ABC News -- Wire)
European Chemical Makers Seeing Limited Recovery in Demand, Jourquin Says Oct 4, 2009
Companies are using more of their capacity, although some prices are still falling, said Jourquin, whos also chief executive officer of , the Belgian producer of chemicals and plastics that announced on Sept. 28 that it agreed to sell its drug unit to Abbott Laboratories. We are leaving the depression mode to come more to a recession mode, Jourquin told reporters in Lisbon today after a conference of the European Chemical Industry Council, or Cefic. (Bloomberg -- Europe)
President Gets French Lesson To Remember Oct 3, 2009
Six times so far this year, acquisition opportunity knocked for Abbott Laboratories. Each time, the drug and medical device maker answered with cash in hand. (Investors Business Daily)
World markets slide ahead of key US jobs report Oct 2, 2009
Large acquisitions announced overnight by Abbott Laboratories and Xerox Corp. helped Wall Street break a three-day slide. The $6 billion-plus deals raised hopes of a rebirth in takeover activity and a recovery of the financial system. (Fresno Bee -- Business)
Boston Scientific Agrees to Pay J&J $716 Million in Stent Settlement Oct 1, 2009
A couple months ago, we reported that Abbott Laboratories and Medtronic had signed a. Now comes news that two more major stent players -- Boston Scientific and Johnson & Johnson's Cordis unit -- have settled more than a dozen stent-related patent suits. (Law.com)
Sanofi to expand in emerging markets to bolster growth Oct 1, 2009
Abbott Laboratories announced this week it will purchase Solvays pharmaceutical unit for e4. 8 billion. (India Times)
Mergers give market a shot in the arm Sep 30, 2009
Large acquisitions from Abbott Laboratories and Xerox Corp. pushed shares of drugmakers and technology companies higher, and the buying spread to other parts of the market as investors hoped that the $6 billion-plus deals could be a sign that takeover activity is finally picking up. Resumption of corporate takeovers would represent an important milepost in the recovery of the financial system. (Honolulu Advertiser)
Boston Sci to Pay J&J $716 Million to Settle Suits Sep 30, 2009
Their products, which have been enmeshed in patent litigation for years, are now facing competition from rivals from Abbott Laboratories and Medtronic Inc. (Reporting by Bill Berkrot; editing by Andre Grenon). (ABC News -- Wire)
US stocks fall after consumer confidence dips Sep 30, 2009
Stocks jumped Monday as news of large takeovers by Xerox Corp. and Abbott Laboratories brought hope that corporate dealmaking could be making a comeback. That would be a big positive not only for the economy but also for the stock market as investors try to figure out which companies could become acquisition targets. (The Star Online, Malaysia -- Business)
Asia markets mixed as US confidence drops Sep 30, 2009
Large acquisitions announced overnight by Abbott Laboratories and Xerox Corp. helped Wall Street break a three-day slide ... Earlier in Asia, stocks bounced back following Monday's big gains in Europe and the U.S. in the wake of Abbott Laboratories' acquisition of the pharmaceutical business of Belgian chemicals maker Solvay for $6. (Fresno Bee -- Business)
Abbott buys Solvay pharma operations for $6.6B Sep 30, 2009
NEW YORK Abbott Laboratories on Monday said it would pay $6. 6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio. (Yahoo News -- Pharmaceutical Industry News)
Solvay sells pharma division to Abbott for $7.6B Sep 30, 2009
BRUSSELS Solvay, the Belgian chemical and pharmaceutical group, said Monday it has agreed to sell its entire pharmaceutical business to Abbott Laboratories of Abbott Park, Illinois, for euro5. 2 billion ($7. (Yahoo News -- Pharmaceutical Industry News)
Sanofi's CEO Viehbacher to Keep Shopping for Biotechs, Vaccines, New Drugs Sep 30, 2009
Abbott Laboratories announced this week it will purchase of Solvay SAs pharmaceutical unit for 4. 8 billion euros. (Bloomberg)
Abbott Laboratories Highlights Stent Test Results Sep 24, 2009
WASHINGTON (September 23, 2009)--Abbott Laboratories said Tuesday results of a large study put its artery-opening Xience stent on equal footing with competitor Boston Scientific in diabetics, a difficult-to-treat group of patients. Abbott said there was no difference in safety complications between diabetic patients with a Xience drug-coated stent, compared to Boston Scientific's Taxus Express stent. (KWTX.com, TX)
Boston Scientific PROMUS(R) and First-Generation TAXUS(R) Express(R) Stents Continue Excellent Performance in SPIRIT III Trial Sep 22, 2009
XIENCE is a trademark of Abbott Laboratories Group of Companies. The safety and effectiveness of the TAXUS Express Stent has not been established in diabetic patients. (PR Newswire)
FDA Approves Donor Screening Test for Antibodies to HIV Sep 19, 2009
The Abbott Prism HIV O Plus assay and the Abbot Prism system are manufactured by Abbott Laboratories, Abbott Park, Ill. Consumer Inquiries: 1-888-INFO-FDA. (PR Newswire)
FDA Approves New HIV Test From Abbott Laboratories Sep 19, 2009
FDA approves Abbott Laboratories' test that screens for HIV types 1 and 2 ... The Food and Drug Administration has approved a new test from Abbott Laboratories that detects both types of the virus that causes AIDS.. (ABC News -- Wire)
Boston Scientific Announces Schedule of Events at TCT Conference Sep 17, 2009
XIENCE V is a trademark of Abbott Laboratories group of companies. The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific. (PR Newswire)
U.S. Medicare may pay for HIV testing Sep 11, 2009
Other companies that make such screening products include Abbott Laboratories and Johnson & Johnson's Ortho-Clinical Diagnostics Inc.. HIV tests have been available in the United States since 1985, but it was not until earlier this year that CMS was allowed by law to consider covering more preventive medical services. (MSNBC -- Health)
Fines unlikely to end off-label drug marketing Sep 5, 2009
"If you had to stick to labeling, you couldn't treat people," said Ruderman, who has done some consulting work for Abbott Laboratories and received research grants from several drugmakers. Ruderman noted that common uses often are technically off-label because it's expensive and often unprofitable for companies to pursue FDA approval for every possible use of their drug. (MSNBC -- Health)
Deloitte & Touche Tops BusinessWeek's Annual List of 'Best Places to Launch a Career' Sep 4, 2009
BusinessWeek's 50 Best Places to Launch a Career 2009 2008 Company Industry Rank Rank ------- -------- ---- ---- 1 2 Deloitte & Touche Accounting 2 1 Ernst & Young Accounting 3 3 PricewaterhouseCoopers Accounting 4 5 KPMG Accounting 5 12 U.S. State Dept. Nonprofit/Government 6 4 Goldman Sachs Investment Banking 7 11 Teach for America Nonprofit/Government 8 14 Target Retail 9 10 J.P. Morgan Investment Banking 10 9 IBM Technology 11 47 Accenture Consulting 12 24 General Mills Consumer Products 13... (PR Newswire)
Investing: Handicapping the Caps Sep 1, 2009
In health care, that quest for higher growth rates has spurred McCain to sell Abbott Laboratories () in order to buy Covance () and Henry Schein (). In retail, the same approach would cause investors to sell a more familiar, safe bet like Wal-Mart () and buy a smaller, more volatile stock like Urban Outfitters (), he says. (BusinessWeek)
SkyePharma Needs Additional Flutiform Tests, Delaying U.S. Introduction Sep 1, 2009
U.S. partner Abbott Laboratories is responsible for the payment of additional trials ordered by the FDA though it is entitled to recoup as much as 25 percent of such costs from milestones and royalties, the U.K. drugmaker said in a statement today. Last Updated: September 1, 2009 02:09 EDT. (Bloomberg -- UK)
The Case for Actively Managed Funds Aug 29, 2009
The p-e's for some Sanies, including Abbott Laboratories, Apollo Group, and Dean Foods, have actually fallen since March. The steepest discounts remain in what Robert Arnott, chairman of Research Affiliates in Newport Beach, Calif. (BusinessWeek)
Howrey Can Use 'Ethical Wall' Over Client's Objections Aug 29, 2009
Howrey is one of several firms representing medical supplies maker Boston Scientific in a trio of related lawsuits against health care product giant Johnson & Johnson and heart subsidiary Cordis Corp. Boston Scientific asked the court to rule that the drug-coated Promus heart stent it makes for Abbott Laboratories doesn't violate Johnson & Johnson patents. Howrey also represents Boston Scientific in a fourth related lawsuit, which names Wyeth as a defendant because it licenses the patent for the... (Law.com)
Abbott to develop cancer gene test with Pfizer Aug 28, 2009
(AP) Abbott Laboratories said Thursday it will develop a test intended to identify patients who might be helped by a lung cancer drug being studied by Pfizer Inc.. The test is intended to scan non-small cell lung cancer tumors for a genetic mutation that exists only in those tumors and some other cancers, but not in healthy cells. (Crain's Chicago Business)
Drug, Biotech Research Spending Hangs Tough Aug 28, 2009
Abbott Laboratories (), which increased its research budget by $44 million, or 3. 5%, views research as essential to remaining a viable health-care company. (BusinessWeek)
New test quickly identifies heart attack Aug 27, 2009
The studies looked at four tests made by Abbott Laboratories, Roche, and Siemens AG. The Abbott and Siemens tests are approved for use in the United States. Until this point, we really did not have direct evidence that they improved overall diagnostic accuracy, said cardiologist Dr. David Morrow of Brigham and Women s Hospital. (Boston Globe)
Money great salve for ills Aug 22, 2009
Abbott Laboratories Inc. Chairman and Chief Executive Miles White's compensation was $25. 3 million in 2008. (Albany Times Union)
AXT announces CFO change Aug 21, 2009
From May 2002 to June 2004, he was corporate controller of Therasense Inc. (now Abbott Laboratories). He's also been a director of accounting for AT&T and worked for BDO Seidman in San Francisco and Deloitte & Touche in South Africa. (San Jose Business Journal, CA)
Vanderbilt joins national consortium to develop new cancer therapies Aug 20, 2009
D., who previously led cancer drug discovery efforts at Abbott Laboratories, will make Vanderbilt "one of the best academic institutions doing cancer drug discovery in the country," Marnett said. Other Vanderbilt investigators involved in this effort include. (EurekAlert! -- Business News)
Abbott expanding study of its popular Xience stent Aug 16, 2009
Abbott Laboratories Inc. is expanding a study of its top-selling heart stent by more than 2,000 patients, who may also be put in a second, landmark stent study meant to find the best way to prevent potentially fatal blood clots. The bigger study aims to determine the optimum time people should take blood-thinning medicines after they undergo a common procedure called angioplasty to clear out a blocked artery and implant a stent, a metal-mesh scaffold that props open a blood vessel. (Longview Daily News, WA)
FDA Warns of Faulty Results With Blood Sugar Tests Aug 15, 2009
Public health regulators told consumers on Friday not to use certain glucose testing strips from Roche, Abbott Laboratories and other companies in combination with dialysis and other biologic drugs. According to FDA those formulations contain non-glucose sugars, which can falsely elevate blood sugar results and increase the risk of insulin overdose. (ABC News -- Wire)
How well do you know pharmaceuticals? Aug 14, 2009
a. The chairman of the Federal Trade Commission b. The chairman of Abbott Laboratories c. The head of the Food and Drug Administration d. The head of Consumers Union ... a. The chairman of the FTC b. The chairman of Abbott Laboratories c. The head of the FDA d. The head of Consumers Union. (Herald Online, SC -- Opinion)
Some companies left behind in bull's dust Aug 12, 2009
Real solutions for your real estate needs. Choose from the selections below. (USA Today -- Money)
Stock questions? Ask Matt Aug 7, 2009
Relying on dividend-paying stocks for income comes with risks - USATODAY.com. Relying on dividend-paying stocks for income comes with risks. (USA Today -- Money)
FDA: Arthritis Drugs Up Kid's Cancer Risks Aug 6, 2009
Shares of North Chicago-based Abbott Laboratories and New Brunswick, N.J.-based J after the FDA announcement. Along with updating the drugs' labels, the FDA is requiring companies to add information about cancer risks to the medication guides given to patients. (CBS News -- Health)
Warnings strengthened on arthritis drugs Aug 6, 2009
The FDA will bolster the "black box" warning on the five drugs sold in the United States, including Abbott Laboratories' Humira, Johnson on's Remicade and Simponi, and Enbrel, which is co-marketed by Amgen Inc. and Wyeth. All the products are multibillion-dollar sellers. (San Francisco Chronicle)
Takeda Leads Japan Drugmakers' Revenue Drop as Stronger Yen Hurts Earnings Aug 1, 2009
3 billion yen in one-time costs in the same quarter of last year for the takeover of Millennium Pharmaceuticals Inc. and the splitting of a U.S. venture with Abbott Laboratories. The profit calculation excludes these costs. (Bloomberg -- Japan)
Stocks to watch: Wockhardt,Matrix Labs, Maytas, Balaji Telefilms Jul 29, 2009
Wockhardt, a leading bio-pharmaceutical company in the country, has sold its nutritionals business comprising top-selling brands Farex, Protinex, Dexolac and Nusobee, and manufacturing units at Lalru and Jagraon in Punjab to Abbott Laboratories for $130 million (around Rs 627 crore). The incidence of failure to meet the quality norms in the pharmaceutical sector has been on the rise. (India Times)
Wockhardt sells nutritionals biz Jul 29, 2009
MUMBAI: Wockhardt, a leading bio-pharmaceutical company in the country, has sold its nutritionals business comprising top-selling brands Farex, Protinex, Dexolac and Nusobee, and manufacturing units at Lalru and Jagraon in Punjab to Abbott Laboratories for $130 million (around Rs 627 crore) ... Wockhardt has sold its nutritionals business comprising top-selling brands Farex, Protinex, Dexolac and Nusobee, and manufacturing units at Lalru and Jagraon in Punjab to Abbott Laboratories for $130... (India Times)
Medtronic to Settle Abbott Stent Suit for $400 Million Jul 28, 2009
Medtronic Inc. said Monday it agreed to pay Abbott Laboratories $400 million to settle patent lawsuits related to the design of artery-opening stents, some of the most lucrative medical devices marketed by either company. The two companies agreed not to sue each other for at least 10 years over matters related to stents, which are mesh metal tubes used to prop open arteries that have been cleared of fatty plaque. (Law.com)
Accuray Announces CyberKnife Access Remote Service Product Jul 27, 2009
The award-winning Axeda ServiceLink solution helps companies, including Abbott Laboratories, Diebold and EMC, proactively service and support products to drive optimal uptime at the lowest possible cost, while enabling enterprises to effectively secure, control and track all remote access to critical data centers. In 2006, Axeda became the first and only remote service application provider to receive the prestigious VeriSign(R) Security Certification. (PR Newswire)
Why Can Some Patients Get Free Drugs While Others Can't? Jul 25, 2009
When Miller's doctor suggested Humira, an injected medicine manufactured by Abbott Laboratories () for her arthritis pain, she didn't think she could afford the nearly $300 co-pay. Her doctor suggested applying for a co-pay assistance program through the pharmaceutical company that makes the drug. (BusinessWeek)
FDA Warns Abbott on Magic Johnson DVD for HIV Drug Jul 24, 2009
NEW YORK (Reuters) - The U.S. Food and Drug Administration sent a warning letter to Abbott Laboratories, citing what it called serious violations in a promotional DVD about its HIV drug Kaletra that the agency said includes misleading information about the medicine. The letter says the violations, seen in a DVD featuring basketball legend and HIV sufferer Earvin "Magic" Johnson, are of public health concern "because they suggest that Kaletra is safer and more effective than has been demonstrated... (MEDLINEplus)
Newsweek: The next blockbuster drugs Jul 23, 2009
One of the top immune system suppressants and the top-selling immunomodulator overall is the Abbott Laboratories Inc. drug Humira, which works to shut down the body's inflammatory response for patients with arthritis and Crohn's disease. It was created using a particular type of human immune cell, which was a clone of a single parent cell. (MSNBC -- Health)
NL Industries Hit With $179 Million Jury Verdict Jul 21, 2009
Right before he started the NL trial, he was local counsel for Johnson & Johnson's Centocor Ortho Biotech unit in a patent infringement trial against Abbott Laboratories. The jury in that case, in which Sayles delivered a fiery closing argument, awarded his client $1. (Law.com)
Abbott profit dips on charges, generic competition Jul 16, 2009
AP FILE - In this July 13, 2005 file photo provided by Abbott Laboratories, the North Chicago-based company's ... Drug developer and medical device maker Abbott Laboratories said Wednesday its second-quarter profit fell 3 percent on a mix of buyout charges and lower drug sales, but the results still met Wall Street forecasts. (Yahoo News -- Press Releases)
Stocks Extend Gains In Lighter Trade Jul 16, 2009
Among a host of companies reporting earnings Wednesday: Abbott Laboratories (), AMR Corp. (), Charles Schwab (), Knight Capital Group (), Wolverine World Wide () and W.W. Grainger () ... Hospira (HSP) is a 2004 spinoff of Abbott Laboratories (ABT) that has found its footing in the drug business. (Investors Business Daily)
Solvay rides high on drugs auction news Jul 16, 2009
Nycomed, the privately owned Swiss company, is in the second round of the auction process, while US drug company Abbott Laboratories was said to be mulling an offer for Solvays TriCor cholesterol treatment, distributed in the US.. EDITORS CHOICE. (FT.com -- Markets)
Roxanne Austin Named President and CEO of Move Networks Jul 14, 2009
"market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-14400", "open" : "1247578216", "close" : "1247601616", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000". Search for share prices. (Yahoo! Wire -- Entertainment News)
City Welcomes Another Business to Grant Place Jul 14, 2009
Each year thousands of people visit the city to attend Navy recruit graduations, visit world renowned Abbott Laboratories, receive treatment from the V.A. Hospital, and attend the Rosalind Franklin University of Medicine and Science. This community of 35,918 is one of the busiest destinations on the lake. (PR Newswire)
Abbott, GlaxoSmithKline to work on cancer test Jul 14, 2009
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of; Miles WhiteChairman of the Board, Chief Executive Officer Thomas FreymanChief Financial Officer, Executive Vice President - Finance From The Lists Your resource for everything related to business in Chicago. 8. (Crain's Chicago Business)
Business Briefing Jul 13, 2009
-- Second-quarter reports expected from Abbott Laboratories, AMR and Gannett. TH. (San Francisco Chronicle -- Business)
Is This the Next Incredible Buying Opportunity? Jul 12, 2009
But if we aren't out of the woods yet, I'll take my chances with blue chips like Kimberly-Clark (NYSE:KMB)and Abbott Laboratories (NYSE: ABT). The next stepEven if this appears to be a good time to invest, how should you do it. (MSNBC -- Business)
Merck, Portola in $470M deal for anticlotting drug Jul 10, 2009
That was after another analyst downgraded Merck stock to "Hold" from "Buy"-on speculation that the unexpected, early end of a researcher's study comparing Merck's cholesterol drug Zetia with Abbott Laboratories Inc.'s Niaspan might mean that the Niaspan patients fared better. 2009 Associated Press. (NJ.com -- News)
Wall Street US stocks eke out gains Jul 10, 2009
01 on speculation its Zetia cholesterol drug fared poorly in a clinical trial comparing it to a drug from Abbott Laboratories. Merck was the biggest weight on the Dow. (Sydney Morning Herald -- Business)
Appeals court rules for Abbott in AIDS drug case Jul 8, 2009
A federal appeals court has rejected a lawsuit accusing Abbott Laboratories of antitrust violations over a sudden 400-percent price hike of a popular AIDS drug ... A federal appeals court has rejected a lawsuit accusing Abbott Laboratories of antitrust violations over a sudden 400-percent price hike of a popular AIDS drug ... SAN FRANCISCO -- A federal appeals court has rejected a lawsuit accusing Abbott Laboratories of antitrust violations over a sudden 400-percent price hike of a popular AIDS... (Fresno Bee -- Business)
"Brave" Post-Lehman M&A Rewarded by Market -Study Jul 6, 2009
Among them, Cisco Systems Inc, Johnson on, Abbott Laboratories , BG Group Plc , and Symantec Corp all outperformed world, regional and sector indexes. However, other multiple acquirers such as Eli Lilly and Co , Medtronic Inc and Banco Santander SA underperformed on some or all measures. (ABC News -- Wire)
FDA advisers vote to take Vicodin... Jul 2, 2009
Abbott Laboratories, which makes the brand-name Vicodin, which has also been available as a generic since the mid-1980s, said in a statement that "today's discussion is an important continuation of the dialog around balancing patient safety with the need for treatment options for patients in pain.". It said, "Pain affects 75 million Americans, more than diabetes, cancer and heart disease combined" and added that it would follow the FDA's final determination. (CNN -- Law)
J&J and Wyeth Bring the Pain Jul 2, 2009
The FDA panel also voted in favor of recalling prescription drugs containing acetaminophen, such as Abbott Laboratories' () Vicodin and Endo Pharmaceuticals' () Percocet. The branded versions and their generic counterparts were prescribed 124 million times last year, making them the most popular class of prescription drug on the market. (BusinessWeek)
